Hotline: 16297 (9.00 AM to 11.00 PM) 
Hello, Sign in 
Cart 
.svg)
Novartis Myfortic 180mg Tablet suppresses immune responses in renal transplant patients. This gastro-resistant medicine inhibits IMPDH to prevent lymphocyte proliferation. Enteric-coated Mycophenolate Sodium manages organ rejection risks.
Key Features
- Organ Rejection Prevention: Mycophenolate Sodium stops the body from attacking new kidney tissue. Inhibits lymphocyte growth for transplant health.
- Enteric Coating: Gastro-resistant barrier protects the stomach lining from direct drug contact. Reduces gastric irritation during digestion.
- Novartis Manufacture: Novartis (Bangladesh) Ltd. produces these 180mg enteric-coated tablet strips. Local production maintains supply during high humidity.
Frequently Asked Questions
What is Myfortic 180mg used for?
It prevents kidney rejection in adult transplant patients. The drug blocks the enzyme needed for T and B cell growth.
Can Myfortic be taken with food?
Take this tablet on an empty stomach. Food intake alters how the body absorbs Mycophenolate Sodium.
